173 related articles for article (PubMed ID: 16411667)
1. Activation of carboplatin by carbonate.
Di Pasqua AJ; Goodisman J; Kerwood DJ; Toms BB; Dubowy RL; Dabrowiak JC
Chem Res Toxicol; 2006 Jan; 19(1):139-49. PubMed ID: 16411667
[TBL] [Abstract][Full Text] [Related]
2. Role of carbonate in the cytotoxicity of carboplatin.
Di Pasqua AJ; Goodisman J; Kerwood DJ; Toms BB; Dubowy RL; Dabrowiak JC
Chem Res Toxicol; 2007 Jun; 20(6):896-904. PubMed ID: 17497898
[TBL] [Abstract][Full Text] [Related]
3. Modification of carboplatin by Jurkat cells.
Di Pasqua AJ; Goodisman J; Kerwood DJ; Toms BB; Dabrowiak JC
J Inorg Biochem; 2007 Oct; 101(10):1438-41. PubMed ID: 17655933
[TBL] [Abstract][Full Text] [Related]
4. Adsorption of the Pt(II) anticancer drug carboplatin by mesoporous silica.
Di Pasqua AJ; Wallner S; Kerwood DJ; Dabrowiak JC
Chem Biodivers; 2009 Sep; 6(9):1343-9. PubMed ID: 19774597
[TBL] [Abstract][Full Text] [Related]
5. Formation of carbonato and hydroxo complexes in the reaction of platinum anticancer drugs with carbonate.
Di Pasqua AJ; Centerwall CR; Kerwood DJ; Dabrowiak JC
Inorg Chem; 2009 Feb; 48(3):1192-7. PubMed ID: 19113934
[TBL] [Abstract][Full Text] [Related]
6. Activation of carboplatin by carbonate: a theoretical investigation.
Ciancetta A; Coletti C; Marrone A; Re N
Dalton Trans; 2012 Nov; 41(41):12960-9. PubMed ID: 22991096
[TBL] [Abstract][Full Text] [Related]
7. Modification and uptake of a cisplatin carbonato complex by Jurkat cells.
Centerwall CR; Tacka KA; Kerwood DJ; Goodisman J; Toms BB; Dubowy RL; Dabrowiak JC
Mol Pharmacol; 2006 Jul; 70(1):348-55. PubMed ID: 16632646
[TBL] [Abstract][Full Text] [Related]
8. Comparison of different theory models and basis sets in the calculations of structures and 13C NMR spectra of [Pt(en)(CBDCA-O, O')], an analogue of the antitumor drug carboplatin.
Gao H; Wei X; Liu X; Yan T
J Phys Chem B; 2010 Mar; 114(11):4056-62. PubMed ID: 20199040
[TBL] [Abstract][Full Text] [Related]
9. The influence of methionine-containing peptides on the reaction of carboplatin with 5'-guanosine monophosphate: a comparison with cisplatin.
Kleine M; Wolters D; Sheldrick WS
J Inorg Biochem; 2003 Dec; 97(4):354-63. PubMed ID: 14568240
[TBL] [Abstract][Full Text] [Related]
10. Experimental and theoretical studies on the pharmacodynamics of cisplatin in jurkat cells.
Tacka KA; Szalda D; Souid AK; Goodisman J; Dabrowiak JC
Chem Res Toxicol; 2004 Nov; 17(11):1434-44. PubMed ID: 15540941
[TBL] [Abstract][Full Text] [Related]
11. The activation of platinum(II) antiproliferative drugs in carbonate medium evaluated by means of a DNA-biosensor.
Ravera M; Bagni G; Mascini M; Dabrowiak JC; Osella D
J Inorg Biochem; 2007 Jul; 101(7):1023-7. PubMed ID: 17524484
[TBL] [Abstract][Full Text] [Related]
12. Monitoring local disposition kinetics of carboplatin in vivo after subcutaneous injection in rats by means of 195Pt NMR.
Becker M; Port RE; Zabel HJ; Zeller WJ; Bachert P
J Magn Reson; 1998 Jul; 133(1):115-22. PubMed ID: 9654475
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin carbonato complexes. Implications for uptake, antitumor properties, and toxicity.
Centerwall CR; Goodisman J; Kerwood DJ; Dabrowiak JC
J Am Chem Soc; 2005 Sep; 127(37):12768-9. PubMed ID: 16159248
[TBL] [Abstract][Full Text] [Related]
14. Guanine binding of a cytotoxic platinum-acridin-9-ylthiourea conjugate monitored by 1-D 1H and 2-D [1H,15N] NMR spectroscopy: hydrolysis is not the rate-determining step.
Guddneppanavar R; Wright MW; Tomsey AK; Bierbach U
J Inorg Biochem; 2006 May; 100(5-6):972-9. PubMed ID: 16488016
[TBL] [Abstract][Full Text] [Related]
15. Characterization of active phosphorus surface sites at synthetic carbonate-free fluorapatite using single-pulse 1H, 31P, and 31P CP MAS NMR.
Jarlbring M; Sandström DE; Antzutkin ON; Forsling W
Langmuir; 2006 May; 22(10):4787-92. PubMed ID: 16649796
[TBL] [Abstract][Full Text] [Related]
16. Influence of dT20 and [d(AT)10]2 on cisplatin hydrolysis studied by two-dimensional [1H,15N] HMQC NMR spectroscopy.
Vinje J; Sletten E; Kozelka J
Chemistry; 2005 Jun; 11(13):3863-71. PubMed ID: 15827978
[TBL] [Abstract][Full Text] [Related]
17. New extracellular resistance mechanism for cisplatin.
Centerwall CR; Kerwood DJ; Goodisman J; Toms BB; Dabrowiak JC
J Inorg Biochem; 2008; 102(5-6):1044-9. PubMed ID: 18294693
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, potentiometric, kinetic, and NMR Studies of 1,4,7,10-tetraazacyclododecane-1,7-bis(acetic acid)-4,10-bis(methylenephosphonic acid) (DO2A2P) and its complexes with Ca(II), Cu(II), Zn(II) and lanthanide(III) ions.
Kálmán FK; Baranyai Z; Tóth I; Bányai I; Király R; Brücher E; Aime S; Sun X; Sherry AD; Kovács Z
Inorg Chem; 2008 May; 47(9):3851-62. PubMed ID: 18380456
[TBL] [Abstract][Full Text] [Related]
19. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
[TBL] [Abstract][Full Text] [Related]
20. Site selectivity in the protonation of a phosphinito bridged Pt(I)-Pt(I) complex: a combined NMR and density-functional theory mechanistic study.
Latronico M; Polini F; Gallo V; Mastrorilli P; Calmuschi-Cula B; Englert U; Re N; Repo T; Räisänen M
Inorg Chem; 2008 Nov; 47(21):9779-96. PubMed ID: 18826212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
